Charlesbank Capital Partners has invested in HBox to enhance its virtual care capabilities, supporting the transformation of care for high-risk chronic patients in independent specialty clinics.
Information on the Target
HBox is a prominent virtual care platform dedicated to supporting independent specialty clinics. The platform offers an integrated, AI-driven solution that merges connected medical devices, patient engagement tools, and comprehensive care services to effectively establish a virtual clinic within existing clinic environments. HBox serves primarily cardiology and various specialty teams, facilitating the delivery of care beyond traditional in-person settings. This innovative approach allows healthcare providers to manage larger populations suffering from chronic conditions while ensuring that they receive high-quality, personalized care.
With its technology, HBox enables healthcare practitioners to maintain close contact with patients, enhancing the overall care experience and ensuring that chronic health issues are effectively monitored and addressed. The platform's ability to extend the reach of healthcare services not only improves patient outcomes but also supports specialty clinics in managing their workload efficiently.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The virtual care industry in the United States has seen significant transformation in recent years, driven by advancements in technology and the increasing demand for accessible healthcare solutions. As patients seek more convenient ways to receive care, the market for
Similar Deals
Marlin Equity Partners → Intelligent Locations
2025
Rittenhouse Ventures → S2N Health, Inc.
2025
Charlesbank
invested in
HBox
in 2025
in a Other VC deal